Gene · 4818
NKG7: natural killer cell granule protein 7
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NKG7: natural killer cell granule protein 7. Genes, record 4818. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4818
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16617 | Protein NKG7 | 165 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025147176 A | 2025-10-06 | 9375 | Q16617 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2847 | Q16617 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7143 | Q16617 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2847 | Q16617 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7143 | Q16617 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 9375 | Q16617 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 9375 | Q16617 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 9382 | Q16617 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 55498 | Q16617 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 3321 | Q16617 | Espacenet |
1 to 10 of 38
See all 38 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,401
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NKG7 papers | Newest fiscal year |
|---|---|---|---|
| UL1TR001863 | Yale Clinical and Translational Science Award | 18 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| P50CA121974 | Yale SPORE in Skin Cancer | 7 | 2025 |
| P01AI039671 | Costimulatory Mechanisms of Autoimmunity | 6 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 6 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 6 | 2025 |
| P50CA101942 | DF/HCC Kidney Cancer SPORE (supplement) | 6 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 6 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 5 | 2025 |
1 to 10 of 1,401Source NIH's project files
See all 1,401 nih grantsPapers1,677
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longxue tongluo capsule enhances ischemic stroke recovery via microbiota-metabolite-gene interactions. | Metab Brain Dis | 2026 | 42804018 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals compartment-specific immune and tumor cell states in a contiguous spinal metastasis. | Neurooncol Adv | 2026 | 42757049 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals distinct immune interaction networks in primary and reactivated HHV-6B infection. | J Infect Dis | 2026 | 42682208 | PubTator, text mining | PubMed |
| Distinct T Cell Repertoires in Spinal Entheses and Synovial Fluids in Ankylosing Spondylitis. | Phenomics | 2026 | 42614581 | PubTator, text mining | PubMed |
| Cytotoxic CD4+ T Cells in Visceral Leishmaniasis Patients. | Parasite Immunol | 2026 | 42609202 | PubTator, text mining | PubMed |
| Natural Killer Cell Granule Protein (NKG7) promotes the development of vaccine-induced anti-fungal Th1 cells. | PLoS Pathog | 2026 | 42536677 | PubTator, text mining | PubMed |
| [A multi-level study of androgen deprivation therapy on the immune microenvironment in prostate cancer]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2026 | 42493444 | PubTator, text mining | PubMed |
| Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner. | NPJ Precis Oncol | 2026 | 42399473 | PubTator, text mining | PubMed |
| Acute exercise shifts inferred immune cell composition and cytotoxic gene programs in pediatric sickle cell anemia. | 3 Biotech | 2026 | 42375599 | PubTator, text mining | PubMed |
| Human NKT10 cells are enriched in cord-derived invariant natural killer T cells and mediate immune-regulation in a xenogeneic graft-versus-host disease model. | Front Immunol | 2026 | 42358969 | PubTator, text mining | PubMed |
1 to 10 of 1,677
See all 1,677 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4818
GET https://conductscience.org/api/genes/v1/4818/patents?page=2